MEGAN CHACHERE: Open Payments
NPI 1942724901 · CROWLEY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 42 payments from 15 companies in 2025. Trend: 2023 $175 · 2024 $291 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $191 |
| Lilly USA, LLC | 5 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Exact Sciences Corporation | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Novo Nordisk Inc | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 5 | $26 |
| Boston Scientific Corporation | 1 | $26 |
| PFIZER INC. | 1 | $18 |
Products named: UBRELVY, CAPLYTA, QULIPTA, MOUNJARO, BREZTRI, VRAYLAR, Cologuard Collection Kit, JARDIANCE.
Industry payments across LA — which companies pay providers there.
